Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: A multi-center observational study

View ORCID ProfileAndrew Ip, View ORCID ProfileJaeil Ahn, Yizhao Zhou, View ORCID ProfileAndre H Goy, Eric Hansen, View ORCID ProfileAndrew L Pecora, Brittany A Sinclaire, Urszula Bednarz, Michael Marafelias, Shivam Mathura, Ihor S Sawczuk, View ORCID ProfileJoseph P Underwood III, David M Walker, Rajiv Prasad, Robert L Sweeney, Marie G Ponce, Samuel LaCapra, Frank J Cunningham, Arthur G Calise, Bradley L Pulver, Dominic Ruocco, Greggory E Mojares, Michael P Eagan, Kristy L Ziontz, Paul Mastrokyriakos, View ORCID ProfileStuart L Goldberg
doi: https://doi.org/10.1101/2020.08.20.20178772
Andrew Ip
1 Division of Outcomes and Value Research, John Theurer Cancer Center at Hackensack University Medical Center;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew Ip
  • For correspondence: andrew.ip@hackensackmeridian.org
Jaeil Ahn
2 Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jaeil Ahn
  • For correspondence: ja1030@georgetown.edu
Yizhao Zhou
2 Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: yz459@georgetown.edu
Andre H Goy
3 John Theurer Cancer Center at Hackensack University Medical Center;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andre H Goy
  • For correspondence: goy.andre@hackensackmeridian.org
Eric Hansen
4 COTA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: erichansen@cotahealthcare.com
Andrew L Pecora
3 John Theurer Cancer Center at Hackensack University Medical Center;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew L Pecora
  • For correspondence: andrew.pecora@hackensackmeridian.org
Brittany A Sinclaire
3 John Theurer Cancer Center at Hackensack University Medical Center;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bderkacs7@gmail.com
Urszula Bednarz
3 John Theurer Cancer Center at Hackensack University Medical Center;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: urszula.bednarz@hackensackmeridian.org
Michael Marafelias
3 John Theurer Cancer Center at Hackensack University Medical Center;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: michael.marafelias@hackensackmeridian.org
Shivam Mathura
4 COTA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: shivammathura@cotahealthcare.com
Ihor S Sawczuk
5 Hackensack Meridian Health, Hackensack Meridian School of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ihor.sawczuk@hackensackmeridian.org
Joseph P Underwood III
6 Hackensack University Medical Center;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joseph P Underwood III
  • For correspondence: joseph.underwoodiii@hackensackmeridian.org
David M Walker
6 Hackensack University Medical Center;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: david.walker@hackensackmeridian.org
Rajiv Prasad
7 Bayshore Medical Center;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rajiv.prasad@hackensackmeridian.org
Robert L Sweeney
8 Jersey Shore University Medical Center;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: robert.sweeney@hackensackmeridian.org
Marie G Ponce
8 Jersey Shore University Medical Center;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mariegrace.ponce@hackensackmeridian.org
Samuel LaCapra
9 JFK Medical Center;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: samuel.lacapra@hackensackmeridian.org
Frank J Cunningham
9 JFK Medical Center;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: frank.cunningham@hackensackmeridian.org
Arthur G Calise
10 Hackensack Meridian Mountainside Medical Center;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: arthur.calise@mountainsidehosp.com
Bradley L Pulver
11 Ocean Medical Center;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bradley.pulver@hackensackmeridian.org
Dominic Ruocco
12 Palisades Medical Center;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dominic.ruocco@hackensackmeridian.org
Greggory E Mojares
13 Pascack Valley Medical Center;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: gregg.mojares@hackensackmeridian.org
Michael P Eagan
14 Raritan Bay Medical Center;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: michael.eagan@hackensackmeridian.org
Kristy L Ziontz
15 Riverview Medical Center;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kristy.ziontz@hackensackmeridian.org
Paul Mastrokyriakos
16 Southern Ocean Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: paul.mastrokyriakos@hackensackmeridian.org
Stuart L Goldberg
1 Division of Outcomes and Value Research, John Theurer Cancer Center at Hackensack University Medical Center;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stuart L Goldberg
  • For correspondence: stuart.goldberg@hackensackmeridian.org
  • Abstract
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background: Hydroxychloroquine has not been associated with improved survival among hospitalized COVID-19 patients in the majority of observational studies and similarly was not identified as an effective prophylaxis following exposure in a prospective randomized trial. We aimed to explore the role of hydroxychloroquine therapy in mildly symptomatic patients diagnosed in the outpatient setting. Methods: We examined the association between outpatient hydroxychloroquine exposure and the subsequent progression of disease among mildly symptomatic non-hospitalized patients with documented SARS-CoV-2 infection. The primary outcome assessed was requirement of hospitalization. Data was obtained from a retrospective review of electronic health records within a New Jersey USA multi-hospital network. We compared outcomes in patients who received hydroxychloroquine with those who did not applying a multivariable logistic model with propensity matching. Results: Among 1274 outpatients with documented SARS-CoV-2 infection 7.6% were prescribed hydroxychloroquine. In a 1067 patient propensity matched cohort, 21.6% with outpatient exposure to hydroxychloroquine were hospitalized, and 31.4% without exposure were hospitalized. In the primary multivariable logistic regression analysis with propensity matching there was an association between exposure to hydroxychloroquine and a decreased rate of hospitalization from COVID-19 (OR 0.53; 95% CI, 0.29, 0.95). Sensitivity analyses revealed similar associations. QTc prolongation events occurred in 2% of patients prescribed hydroxychloroquine with no reported arrhythmia events among those with data available. Conclusions: In this retrospective observational study of SARS-CoV-2 infected non-hospitalized patients hydroxychloroquine exposure was associated with a decreased rate of subsequent hospitalization. Additional exploration of hydroxychloroquine in this mildly symptomatic outpatient population is warranted.

Competing Interest Statement

All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; AHG reports being a study investigator for Genentech-Hoffman La Roche, during the conduct of the study; research funding as study investigator from Acerta, AstraZeneca, Celgene, Kite Pharma, Elsevier's PracticeUpdate Oncology, Gilead, Medscape, MJH Associates, OncLive Peer Exchange, Physicians Education Resource, and Xcenda, outside the submitted work, and research funding as a study investigator for Constellation, Infinity, Infinity Verastem, Janssen, Karyopharm, and Pharmacyclics, outside of the submitted work. EH and SM report consulting for Regional Cancer Care Associates and Hackensack Meridian Health, outside the submitted work. ALP and SLG report having equity ownership in COTA, outside the submitted work. No other relationships or activities that could appear to have influenced the submitted work.

Clinical Trial

NCT04347993

Funding Statement

No external funding was received to support this research.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Hackensack Meridian Health IRB approved this study under #Pro2020-0342. The following waivers were approved for this study: Waiver of consent, and Waiver of HIPAA authorization.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Deidentified Data may be requested directly from Hackensack Meridian Health. Please contact the corresponding author, Dr. Stuart Goldberg, for specific inquiries.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted August 25, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: A multi-center observational study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: A multi-center observational study
Andrew Ip, Jaeil Ahn, Yizhao Zhou, Andre H Goy, Eric Hansen, Andrew L Pecora, Brittany A Sinclaire, Urszula Bednarz, Michael Marafelias, Shivam Mathura, Ihor S Sawczuk, Joseph P Underwood III, David M Walker, Rajiv Prasad, Robert L Sweeney, Marie G Ponce, Samuel LaCapra, Frank J Cunningham, Arthur G Calise, Bradley L Pulver, Dominic Ruocco, Greggory E Mojares, Michael P Eagan, Kristy L Ziontz, Paul Mastrokyriakos, Stuart L Goldberg
medRxiv 2020.08.20.20178772; doi: https://doi.org/10.1101/2020.08.20.20178772
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: A multi-center observational study
Andrew Ip, Jaeil Ahn, Yizhao Zhou, Andre H Goy, Eric Hansen, Andrew L Pecora, Brittany A Sinclaire, Urszula Bednarz, Michael Marafelias, Shivam Mathura, Ihor S Sawczuk, Joseph P Underwood III, David M Walker, Rajiv Prasad, Robert L Sweeney, Marie G Ponce, Samuel LaCapra, Frank J Cunningham, Arthur G Calise, Bradley L Pulver, Dominic Ruocco, Greggory E Mojares, Michael P Eagan, Kristy L Ziontz, Paul Mastrokyriakos, Stuart L Goldberg
medRxiv 2020.08.20.20178772; doi: https://doi.org/10.1101/2020.08.20.20178772

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (46)
  • Cardiovascular Medicine (415)
  • Dentistry and Oral Medicine (70)
  • Dermatology (47)
  • Emergency Medicine (144)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4857)
  • Forensic Medicine (3)
  • Gastroenterology (183)
  • Genetic and Genomic Medicine (676)
  • Geriatric Medicine (70)
  • Health Economics (192)
  • Health Informatics (630)
  • Health Policy (320)
  • Health Systems and Quality Improvement (206)
  • Hematology (85)
  • HIV/AIDS (156)
  • Infectious Diseases (except HIV/AIDS) (5339)
  • Intensive Care and Critical Care Medicine (331)
  • Medical Education (93)
  • Medical Ethics (24)
  • Nephrology (75)
  • Neurology (686)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (126)
  • Occupational and Environmental Health (208)
  • Oncology (439)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (89)
  • Pain Medicine (35)
  • Palliative Medicine (16)
  • Pathology (129)
  • Pediatrics (194)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (780)
  • Public and Global Health (1816)
  • Radiology and Imaging (324)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (62)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (37)